Center For Disease Control (CDC)

Showing 1-8 of 35 results

Clinical scenario: Placing an IUD after unprotected sex

What providers need to know about placing a levonorgestrel intrauterine device (LNG-IUD) after unprotected sex

Research roundup: July 2025 edition

US-MEC 2024 update, NuvaRing for adenomyosis, COCs & psychotropic meds, abortion bans & maternal health, adolescent abortion info

More than just lidocaine: Person-centered pain strategies for IUD placement

Review of evidence-based, person-centered strategies for improving patient comfort during IUD placements, from paracervical blocks to non-medication supports

DoxyPEP: What providers need to know

DoxyPEP is an emerging evidence-based, low-cost tool for STI prevention. Here's what you need to know.

2024 Updates to the U.S. SPR and U.S. MEC

New and updated guidance on the initiation and management of contraception, including pain management options for IUD placement, support for DMPA-SQ, and new conditions and methods added.

Research roundup: December 2024 edition

Clinical trial data on a new IUD, clinical guidance on self-managed abortion, the impact of the ACA on reproductive health, and CDC’s abortion surveillance data.

Research roundup: 2023 highlights

Highlighting one notable research article from each Research Roundup in 2023.

Research roundup: July 2023 edition

Continued support for misoprostol-only regimens for medication abortion and self-managed abortion between nine and 16 weeks gestation, the use of home pregnancy tests for follow-up care after a telehealth medication abortion, where adolescents and young adults go online to get abortion information, and disparities in recommended retesting for women with trichomonas vaginalis infections.
  • Previous
  • 1(current)
  • 2
  • 3
  • 4
  • 5
  • Next